nurx glp-1 reviews Review: Birth Control and More GLP-1 Reviews 2026: Compare 70+

Soaring demand for weight loss drugs, specifically GLP-1 agonists, has propelled Novo Nordisk and Eli Lilly closer to potentially becoming the first pharmaceutical companies with market capitalizations exceeding $1 trillion

This increased workload can lead to fatigue

As a result, many patients explore alternative access options such as cash-pay programs and telehealth-based prescribing

Read the full story and see the results in Fierce Healthcare: #PBM #PharmacyBenefits #GLP1 RxSense helps client keep GLP-1s on formulary with real-time claims adjudication With real-time claims adjudication, configurable benefit tools, and the flexibility to adapt programs quickly, RxSense helped its client keep GLP-1s on formulary

doi: 10.2337/diabetes.54.8.2390 33 BaldisseraFGHolstJJKnuhtsenSHilstedLNielsenOV